Ligands of Immunopharmacology

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

InformationIL-15-IN-1 is a potent and selective inhibitor of Interleukin 15 (IL-15) that inhibits the proliferation of IL-15-dependent cells with IC50 of 0.8 μM.

Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib

Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib

Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 ( COX-2 ) inhibitor with an IC 50 value of 18 nM, it also inhibits COX1- activity with an IC 50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effectIn VitroImrecoxib

INCB086550 (PD-1/PD-L1-IN-8 example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt= 10 nM.Form:Solid

INCB086550 (PD-1/PD-L1-IN-8 example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt= 10 nM.Form:Solid

INCB086550 (PD-1/PD-L1-IN-8 example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt= 10 nM.Form:Solid

INCB086550 (PD-1/PD-L1-IN-8 example 24) is a PD-1/PD-L1 inhibitor, with an IC 50 &lt= 10 nM.

IRAK inhibitor 2 is IRAK4 (interleukin-1 receptor associated kinase 4) inhibitor .Form:Solid